(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

STELLUS RX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

STELLUS RX

ST13

US500000097632114

Class

35, 39, 44, 45

Filing

97632114

Registration

7434761

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

25

Latest update

07/02/2024

Trademark type

Combined

Nice classes

35, 39, 44, 45

Filing date

10/14/2022

Registration date

07/02/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/02/2024

Last transaction

07/02/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

11/07/2022

First use in commerce

11/07/2022

Drawing code

3

Owner type

16

Owner location

Plano, TX, US

Examiner

MEYERS,MORGAN LAURA

Law office

M80

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the words "STELLUS RX" beside a stylized arrangement of line segments in a geometric pattern.

Holders and representatives

Holders

Stellus Rx, LLC

Representatives

Carol M. Wilhelm GRAY REED & MCGRAW LLP

Technical classification

Nice Classes

Class 35Class 39Class 44Class 45

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Retail pharmacy services; Pharmaceutical servicesprocessing online and telephone prescription orders in retail and central fill pharmacies

Class 39

Pharmacy packaging service that alignssorts and packages a patient's medications by date and time into individual packets

Class 44

Medication counseling; Behavioral health services in the nature of medication monitoring services; Value-based pharmacists' services to make up prescriptions

Class 45

Providing patient advocate and case management servicescoordinating the procurement and administration of medication

Publications

History of USPTO decisions and trademark events.

25 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

07/02/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

07/02/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

05/27/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

05/27/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

05/04/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

05/04/2024

IUAF

USE AMENDMENT FILED

04/15/2024

EISU

TEAS STATEMENT OF USE RECEIVED

04/15/2024

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

11/21/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/26/2023

PUBO

PUBLISHED FOR OPPOSITION

09/26/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/06/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/23/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/21/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/21/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/17/2023

CEPE

COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED

08/14/2023

ALIE

ASSIGNED TO LIE

08/12/2023

GEAN

NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

08/11/2023

GEAP

EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

08/11/2023

CPEA

EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED

08/11/2023

DOCK

ASSIGNED TO EXAMINER

07/29/2023

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

10/29/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/28/2022

NWAP

NEW APPLICATION ENTERED

10/18/2022

Continuous trademark protection

Get notified about every new filing that threatens STELLUS RX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.